SCHEMBL8514302

SCHEMBL8514302

CCOC(=O)/C=C1/CCCc2ccc(OC)cc21

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.53
MTNR1A P48039 3/20 0.53
MTNR1B P49286 3/20 0.53
ABCB1 P08183 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
CYP19A1 P11511 4/20 0.41
CYP11B2 P19099 4/20 0.41
BRD4 O60885 1/20 0.40
MAOB P27338 1/20 0.40
RXRA P19793 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514303 1.00 NQO2 (0.53) NQO2MTNR1AMTNR1BABCB1KDM4E
SCHEMBL9290663 1.00 NQO2 (0.53) NQO2MTNR1AMTNR1BABCB1KDM4E
SCHEMBL1470548 0.92 NQO2 (0.61) NQO2MTNR1AMTNR1BKDM4ECYP19A1
SCHEMBL1470545 0.92 NQO2 (0.61) NQO2MTNR1AMTNR1BKDM4ECYP19A1
SCHEMBL12749769 0.92 NQO2 (0.61) NQO2MTNR1AMTNR1BKDM4ECYP19A1
SCHEMBL3004692 0.90 CYP19A1 (0.51) NQO2MTNR1AMTNR1BKDM4EMAPT
SCHEMBL2432831 0.90 CYP19A1 (0.51) NQO2MTNR1AMTNR1BKDM4EMAPT
SCHEMBL12550714 0.86 RXRA (0.53) NQO2MTNR1AMTNR1BKDM4EMAPT
SCHEMBL3894416 0.83 NQO2 (0.49) NQO2MTNR1AMTNR1BABCB1KDM4E
SCHEMBL3894420 0.83 NQO2 (0.49) NQO2MTNR1AMTNR1BABCB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012070025-A1 PROCESS FOR THE PREPARATION OF AGOMELATINE CADILA PHARMACEUTICALS LTD (IN) 2012-05-31 WO claimed
WO-2012070025-A1 PROCESS FOR THE PREPARATION OF AGOMELATINE CADILA PHARMACEUTICALS LTD (IN) 2012-05-31 WO disclosed
US-5449690-A Antihypercholesterol anf melatonin antagonist ADIR ET COMPAGNIE (FR) 1995-09-12 US disclosed
US-5449689-A Treating melatoninergic system disorders ADIR ET COMPAGNIE (FR) 1995-09-12 US disclosed
US-5389683-A Useful in treating or preventing a disorder of the melatoninergic system ADIR ET COMPAGNIE (FR) 1995-02-14 US disclosed
US-5385944-A Naphthylethylureas and naphthylethylthioureas ADIR ET COMPAGNIE (FR) 1995-01-31 US disclosed